Insider trading · Q3 2026 · CIK 1566044

Yarrow Bioscience, Inc. (YARW) insider trading.

In Q3 2026, insiders at Yarrow Bioscience, Inc. reported 9 non-derivative transactions on 23 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.

Transactions
9
Purchases (P)
0
Sales (S)
0
Net shares, P minus S
0
Insiders
5
Last filed
2026-07-30

Insiders

InsiderRelationshipTransactionsBuysSales
Stuart IainOfficer · CHIEF SCIENTIFIC OFFICER200
Domzalski DavidDirector, Officer · PRESIDENT AND CEO200
Harsch MutyaOfficer · CHIEF LEGAL OFFICER AND GC200
Zeronda TylerOfficer · CHIEF FINANCIAL OFFICER200
WONG RODERICK / RTW Fund Group GP, LLCTenPercentOwner100

Transactions

9 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-07-29WONG RODERICK / RTW Fund Group GP, LLCJ (D)133,290$0266,307Form 4
2026-07-23Stuart IainF (D)15,405$0.995,944Form 4
2026-07-23Domzalski DavidF (D)79,391$0.9347,174Form 4
2026-07-23Harsch MutyaF (D)22,516$0.995,918Form 4
2026-07-23Zeronda TylerF (D)22,516$0.974,918Form 4
2026-06-30Stuart IainF (D)2,370$0.65111,349Form 4
2026-06-30Domzalski DavidF (D)12,214$0.65426,565Form 4
2026-06-30Harsch MutyaF (D)3,464$0.65118,434Form 4
2026-06-30Zeronda TylerF (D)3,464$0.6597,434Form 4

Transaction codes in this quarter

Get YARW insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1566044&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · YARW company page · Yarrow Bioscience, Inc. on SEC.gov

Questions

Are insiders buying or selling Yarrow Bioscience, Inc. (YARW)?

In Q3 2026, insiders at Yarrow Bioscience, Inc. reported 9 non-derivative transactions on 23 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Yarrow Bioscience, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/yarw.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.